Search Results - "Tsikas, D."

Refine Results
  1. 1

    Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy by Haghikia, A, Podewski, E, Libhaber, E, Labidi, S, Fischer, D, Roentgen, P, Tsikas, D, Jordan, J, Lichtinghagen, R, von Kaisenberg, C. S, Struman, Ingrid, Bovy, Nicolas, Sliwa, K, Bauersachs, J, Hilfiker-Kleiner, Denise

    Published in Basic research in cardiology (01-07-2013)
    “…Peripartum cardiomyopathy (PPCM) is a life-threatening heart disease developing towards the end of pregnancy or in the months following delivery in previously…”
    Get full text
    Journal Article Web Resource
  2. 2

    Asymmetric dimethylarginine, arginine and homoarginine at 11–13 weeks’ gestation and preeclampsia: a case–control study by Khalil, A A, Tsikas, D, Akolekar, R, Jordan, J, Nicolaides, K H

    Published in Journal of human hypertension (01-01-2013)
    “…The aim of this study was to investigate whether the nitric oxide (NO) pathway is altered in pregnancies that develop preeclampsia (PE). This was a nested…”
    Get full text
    Journal Article
  3. 3

    Recent methodological advances in the mass spectrometric analysis of free and protein-associated 3-nitrotyrosine in human plasma by Tsikas, Dimitrios, Caidahl, Kenneth

    “…l-Tyrosine and l-tyrosine residues in proteins are attacked by various reactive-nitrogen species (RNS) including peroxynitrite to form 3-nitrotyrosine (NO…”
    Get full text
    Journal Article
  4. 4

    Endopeptidase inhibition attenuates the contraction induced by big endothelin‐1 of isolated human penile erectile tissue by Shahin, P., Rahardjo, H. E., Bannowsky, A., Tsikas, D., Sohn, M., Kuczyk, M. A., Ückert, S.

    Published in Andrologia (01-06-2018)
    “…Summary Peptides, such as C‐type natriuretic peptide (CNP), vasoactive intestinal polypeptide (VIP) and endothelin 1 (ET‐1), are involved in the control of…”
    Get full text
    Journal Article
  5. 5

    Bone marrow molecular alterations after myocardial infarction : Impact on endothelial progenitor cells by THUM, Thomas, FRACCAROLLO, Daniela, GALUPPO, Paolo, TSIKAS, Dimitrios, FRANTZ, Stefan, ERTL, Georg, BAUERSACHS, Johann

    Published in Cardiovascular research (01-04-2006)
    “…Standard drugs post-myocardial infarction (MI) such as angiotensin converting enzyme (ACE) and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase…”
    Get full text
    Journal Article
  6. 6

    Allergen Challenge Increases Anandamide in Bronchoalveolar Fluid of Patients With Allergic Asthma by Zoerner, A A, Stichtenoth, D O, Engeli, S, Batkai, S, Winkler, C, Schaumann, F, Janke, J, Holz, O, Krug, N, Tsikas, D, Jordan, J, Hohlfeld, J M

    Published in Clinical pharmacology and therapeutics (01-09-2011)
    “…Preclinical studies suggest that the endocannabinoid anandamide restrains allergic airway obstruction and inflammation. Therefore, we applied saline or…”
    Get full text
    Journal Article
  7. 7

    Early Renal Ischemia‐Reperfusion Injury in Humans Is Dominated by IL‐6 Release from the Allograft by De Vries, D. K., Lindeman, J. H. N., Tsikas, D., De Heer, E., Roos, A., De Fijter, J. W., Baranski, A. G., Van Pelt, J., Schaapherder, A. F. M.

    Published in American journal of transplantation (01-07-2009)
    “…The pathophysiology of ischemia/reperfusion (I/R) injury is complex, and current knowledge of I/R injury in humans is incomplete. In the present study, human…”
    Get full text
    Journal Article
  8. 8

    Redox‐generated isoprostanes are associated with residual platelet activity in aspirin‐treated patients with stable coronary heart disease by SCHWEDHELM, E., BIEREND, A., MAAS, R., TRINKS, R., KOM, G. D., TSIKAS, D., BÖGER, R. H.

    Published in Journal of thrombosis and haemostasis (01-12-2010)
    “…Aim: Insufficient platelet inhibition by low‐dose aspirin is associated with poor prognosis in patients with coronary heart disease (CHD). We sought to…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Influence of dietary fat ingestion on asymmetrical dimethylarginine in lean and obese human subjects by Engeli, S, Tsikas, D, Lehmann, A.C, Böhnke, J, Haas, V, Strauß, A, Janke, J, Gorzelniak, K, Luft, F.C, Jordan, J

    “…Abstract Background and Aims Asymmetrical dimethylarginine (ADMA) may contribute to hypertension and cardiovascular disease by decreasing NO formation. In…”
    Get full text
    Journal Article
  12. 12

    Nebivolol decreases systemic oxidative stress in healthy volunteers by Troost, R., Schwedhelm, E., Rojczyk, S., Tsikas, D., Frölich, J. C.

    Published in British journal of clinical pharmacology (01-10-2000)
    “…Aims Nebivolol is a selective, vasodilatory β1‐adrenergic receptor antagonist which has been suggested to possess additional antioxidative properties. The aim…”
    Get full text
    Journal Article
  13. 13

    Effects of normalization of plasma testosterone levels in hypogonadal men on plasma levels and urinary excretion of asymmetric dimethylarginine (ADMA) by Leifke, E, Kinzel, M, Tsikas, D, Gooren, L, Frölich, J C, Brabant, G

    Published in Hormone and metabolic research (01-01-2008)
    “…Elevated plasma levels of asymmetric dimethylarginine (ADMA) inhibit nitric oxide formation and exert a proatherogenic action. Low testosterone (T) levels are…”
    Get more information
    Journal Article
  14. 14

    Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids by Tsikas, Dimitrios

    Published in Free radical research (01-08-2005)
    “…In human organism, the gaseous radical molecule nitric oxide (NO) is produced in various cells from L-arginine by the catalytic action of NO synthases (NOS)…”
    Get more information
    Journal Article
  15. 15
  16. 16

    L-arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects by Bode-Böger, S M, Böger, R H, Creutzig, A, Tsikas, D, Gutzki, F M, Alexander, K, Frölich, J C

    Published in Clinical science (1979) (01-09-1994)
    “…1. L-Arginine is the physiological precursor of nitric oxide which induces vasodilatation and inhibits platelet aggregation by the formation of cyclic GMP. 2…”
    Get more information
    Journal Article
  17. 17

    Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells by Bauer, H, Jung, T, Tsikas, D, Stichtenoth, D O, Frölich, J C, Neumann, C

    Published in Immunology (01-02-1997)
    “…Mechanisms regulating the balance of T-helper 1 (Th1) and T-helper 2 (Th2) immune responses are of great interest as they may determine the outcome of allergic…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Vaso-occlusion in Schimke-immuno-osseous dysplasia: is the NO pathway involved? by Lücke, T, Tsikas, D, Kanzelmeyer, N K, Boerkoel, C F, Clewing, J M, Vaske, B, Ehrich, J H H, Das, A M

    Published in Hormone and metabolic research (01-10-2006)
    “…Schimke-immuno-osseous dysplasia (SIOD) is an autosomal recessive disorder with the main clinical findings of spondyloepiphyseal dysplasia, nephrotic syndrome,…”
    Get more information
    Journal Article
  20. 20